Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-29

FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc., authorizing a generic Clozapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)